Journal article

High rates of multidrug-resistant and rifampicin-resistant tuberculosis among re-treatment cases: where do they come from?

Romain Ragonnet, James M Trauer, Justin T Denholm, Ben J Marais, Emma S McBryde

BMC Infectious Diseases | BIOMED CENTRAL LTD | Published : 2017

DOI: 10.1186/s12879-016-2171-1

Citation metrics

22Web of Science
21Scopus

Keywords

Life Sciences & Biomedicine
Tuberculosis, Pulmonary
Misdiagnosis
Transmission
Models, Statistical
Tuberculosis
Rifampin
Short-Course Dots
Causal Pathway
Science & Technology
Inappropriate Therapy
Tuberculosis, Multidrug-Resistant
Burden
Antitubercular Agents
Infectious Diseases
Reinfection
Retreatment
Drug Resistance Amplification
Mycobacterium-Tuberculosis
Drug-Resistance
Re-Treatment
Epidemics
South-Africa
Area
Multidrug-Resistant Tuberculosis
World Health Organization
Risk
Humans